Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | CASP3 | P42574 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.58 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.58 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.56 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.56 |
| ▸ | TTR | P02766 | 1/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Flamenol SCHEMBL3190965 | 0.97 | CYP3A4 (0.59) | CYP3A4ALDH1A1TP53SMN1; SMN2NPC1 | |
| SCHEMBL233829 | 0.94 | ALDH1A1 (0.69) | CYP3A4ALDH1A1TP53SMN1; SMN2NPC1 | |
| SCHEMBL31507600 | 0.84 | PTPN1 (0.67) | CYP3A4ALDH1A1TP53SMN1; SMN2NPC1 | |
| SCHEMBL296714 | 0.84 | PTPN1 (0.67) | CYP3A4ALDH1A1TP53SMN1; SMN2NPC1 | |
| SCHEMBL1794250 | 0.82 | CYP3A4 (0.50) | CYP3A4ALDH1A1TP53SMN1; SMN2NPC1 | |
| SCHEMBL422650 | 0.82 | CYP3A4 (0.50) | CYP3A4ALDH1A1TP53SMN1; SMN2NPC1 | |
| SCHEMBL22845360 | 0.82 | CYP3A4 (0.50) | CYP3A4ALDH1A1TP53SMN1; SMN2NPC1 | |
| SCHEMBL440836 | 0.82 | CYP3A4 (0.50) | CYP3A4ALDH1A1TP53SMN1; SMN2NPC1 | |
| SCHEMBL13786716 | 0.82 | CYP3A4 (0.50) | CYP3A4ALDH1A1TP53SMN1; SMN2NPC1 | |
| SCHEMBL522123 | 0.82 | CA1 (0.55) | CYP3A4ALDH1A1TP53SMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1070 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-04-09 | — | — | US | claimed |
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-01-08 | — | — | US | claimed |
| EP-4606226-A2 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| EP-4578292-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| CN-116285829-B | Combined supermolecule adhesive resistant to ultralow temperature and organic solvent | 陕西师范大学 | 2025-04-25 | — | — | CN | claimed |
| US-20250072446-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. | 2025-03-06 | — | — | US | claimed |
| EP-4255208-B1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2024-12-25 | — | — | EP | claimed |
| CN-118742210-A | Chocolate replicas made from multiple individual components | 航行食品股份有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-117916215-A | Indene compound, pharmaceutical composition thereof and therapeutic application thereof | 藤济(厦门)生物医药科技有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117799202-A | Body-adhering film and production process thereof | 江苏优合新材料有限公司 | 2024-04-02 | — | — | CN | claimed |
| EP-1300487-A1 | Plating bath and method for depositing a metal layer on a substrate | Shipley Co. L.L.C. (US) | 2003-04-09 | — | — | EP | claimed |
| US-6054137-A | A THERAPEUTIC TREATMENT FOR STIMULATING PROLIFERATION OF HUMAN KERATINOCYTES AND FOR SKIN DISORDERS | SOCIETE L'OREAL S.A. (FR) | 2000-04-25 | — | — | US | claimed |
| EP-0931542-A1 | Cosmetic composition containing phloroglucinol | L'OREAL (FR) | 1999-07-28 | — | — | EP | claimed |
| US-5866608-A | AROMATIC COMPOUNDS | BIORESEARCH, INC. (US) | 1999-02-02 | — | — | US | claimed |
| US-4473713-A | Hydrolysis of aryl-aliphatic ethers | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1984-09-25 | — | — | US | claimed |
| US-4429138-A | MULTISTEP, FROM PHLOROGLUCINOL | GOUPIL JEAN JACQUES (FR) | 1984-01-31 | — | — | US | claimed |
| US-4384101-A | EPOXIDE, ISOCYANATE, TRIALLYL CYANURATE AS CROSSLINKER FOR THERMOSETTING ELECTRICAL INSULATION | BBC BROWN, BOVERI & COMPANY, LIMITED (CH) | 1983-05-17 | — | — | US | claimed |
| EP-0001733-B1 | 5-METHOXY-PSORALENE AS A NEW MEDICAMENT AND PROCESS FOR THE SYNTHESIS | Goupil, Jean-Jacques (FR) | 1982-06-23 | — | — | EP | claimed |
| US-4112003-A | Process for preparing polyphenols | GIVAUDAN CORPORATION (US) | 1978-09-05 | — | — | US | claimed |
| US-4100118-A | POLYGLYCIDYL ESTER OF A FATTY ACID, ISOCYANATE COMPOUND AND CURING CATALYST, THERMAL RESISTANCE, THERMAL SHOCK RESISTANCE | HITACHI, LTD. (JP) | 1978-07-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | HAAO, PTGES2, PTGES | CYP3A4 173/4885ALDH1A1 74/4885TP53 2682/4885 |
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | HAAO, HTR6, SCD | CYP3A4 583/4885ALDH1A1 492/4885TP53 727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.